Table 3.
Correlation between PNN expression and clinicopathologic characteristics in prostate cancer patients
| Characteristics | PNN Expression | χ2 | P | |
|---|---|---|---|---|
|
| ||||
| Negative and Low (%) | Moderate and High (%) | |||
| PSA Level | 2.021 | 0.364 | ||
| < 10 | 7 (63.6) | 4 (36.4) | ||
| 10-50 | 20 (58.8) | 14 (41.2) | ||
| > 50 | 16 (44.4) | 20 (55.6) | ||
| Gleason Score | 7.546 | 0.023 | ||
| < 7 | 10 (76.9) | 3 (23.1) | ||
| = 7 | 14 (66.7) | 7 (33.3) | ||
| > 7 | 19 (40.4) | 28 (59.6) | ||
| Tumor Stage | 4.941 | 0.026 | ||
| I-II | 33 (61.1) | 21 (38.9) | ||
| III-IV | 9 (34.6) | 17 (65.4) | ||
| Tumor Metastasis | 4.357 | 0.037 | ||
| No | 23 (65.7) | 12 (34.3) | ||
| Yes | 19 (42.2) | 26 (57.8) | ||
| Biochemical Recurrence | 0.102 | 0.750 | ||
| No | 33 (54.1) | 28 (45.9) | ||
| Yes | 10 (50.0) | 10 (50.0) | ||